1-Hydroxybenzotriazole → tert-Butyl 4-(4-((4-(2-(2-amino-2-oxoethyl)phenethyl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-3-ethylphenyl)piperidine-1-carboxylate

HRID 2272432Notes

Reaction equation

HRID 2272432 reaction equation
[CH2:1]([C:3]1[CH:4]=[C:5]([CH:33]2[CH2:38][CH2:37][N:36]([C:39]([O:41][C:42]([CH3:45])([CH3:44])[CH3:43])=[O:40])[CH2:35][CH2:34]2)[CH:6]=[CH:7][C:8]=1[NH:9][C:10]1[N:15]=[C:14]([CH2:16][CH2:17][C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=2[CH2:24][C:25](OC)=[O:26])[C:13]([C:29]([F:32])([F:31])[F:30])=[CH:12][N:11]=1)[CH3:2].O.[OH-].[Li+].C1C=CC2N(O)N=[N:55]C=2C=1.CCN=C=NCCCN(C)C.Cl.CCN(C(C)C)C(C)C.C(=O)([O-])[O-].[NH4+].[NH4+]>C1COCC1.O.CN(C=O)C>[NH2:55][C:25](=[O:26])[CH2:24][C:19]1[CH:20]=[CH:21][CH:22]=[CH:23][C:18]=1[CH2:17][CH2:16][C:14]1[C:13]([C:29]([F:30])([F:31])[F:32])=[CH:12][N:11]=[C:10]([NH:9][C:8]2[CH:7]=[CH:6][C:5]([CH:33]3[CH2:38][CH2:37][N:36]([C:39]([O:41][C:42]([CH3:44])([CH3:45])[CH3:43])=[O:40])[CH2:35][CH2:34]3)=[CH:4][C:3]=2[CH2:1][CH3:2])[N:15]=1

Participants

10

Procedure

tert-Butyl 4-(3-ethyl-4-((4-(2-(2-methoxy-2-oxoethyl)phenethyl)-5-(trifluoromethyl)pyrimidin-2-yl)amino)phenyl)piperidine-1-carboxylate (I43) (177 mg, 0.282 mmol) was dissolved in THF (10 mL), and a solution of lithium hydroxide monohydrate (59.0 mg, 1.41 mmol) in water (2 mL) was added. The mixture was stirred for 18 hours then concentrated. The residue was suspended in saturated sodium bicarbonate (20 mL), and extracted with ethyl acetate (3×20 mL). The combined ethyl acetate phases were washed with brine, dried (sodium sulphate) and evaporated. The residue was dissolved in THF (10 mL) and DMF (1 mL) at 30° C. and HOBt (50 mg, 0.37 mmol), EDCl (65 mg, 0.37 mmol) and DIPEA (0.246 mL, 1.41 mmol) were added. After ten minutes ammonium carbonate (135 mg, 1.41 mmol) was added and the mixture was stirred for 18 hours at 30° C. The mixture was concentrated, the residue diluted with saturated sodium bicarbonate (25 mL) and extracted with ethyl acetate (3×25 mL). The combined ethyl acetate phases were washed with brine (25 mL), dried (sodium sulfate) and evaporated. Chromatography (12 g silica cartridge, 0-100% ethyl acetate/petroleum benzine 40-60° C.) gave the title compound (I44) (122 mg, 71% over two steps) as a white solid; 1H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.56 (d, J=8.1 Hz, 1H), 7.28-7.22 (m, overlaps with CHCl3), 7.22-7.15 (m, 1H), 7.13-7.05 (m, 3H), 5.38 (s, 1H), 5.15 (s, 1H), 4.25 (s, 2H), 3.64 (s, 2H), 3.11-2.99 (m, 4H), 2.80 (t, J=12.1 Hz, 2H), 2.69-2.60 (m, 3H), 1.84 (d, J=12.3 Hz, 2H), 1.69-1.60 (m, 2H), 1.49 (s, 9H), 1.23 (t, J=7.6 Hz, 3H). LCMS: rt 6.65 min; m/z 612.2 [M+H]+, 556.1 [M-tBu+2H]+; m/z 610.2 [M−H]−.

Workup

  1. concentrationthen concentrated
  2. extractionextracted with ethyl acetate (3×20 mL)
  3. washThe combined ethyl acetate phases were washed with brine
  4. dry with materialdried (sodium sulphate)
  5. customevaporated
  6. dissolutionThe residue was dissolved in THF (10 mL)
  7. stirringthe mixture was stirred for 18 hours at 30° C
  8. concentrationThe mixture was concentrated
  9. additionthe residue diluted with saturated sodium bicarbonate (25 mL)
  10. extractionextracted with ethyl acetate (3×25 mL)
  11. washThe combined ethyl acetate phases were washed with brine (25 mL)
  12. dry with materialdried (sodium sulfate)
  13. customevaporated

Sources & evidence

ORD record
ord-d8b538f5051e4b8eb1e608fd7e2ded8c
Source dataset
uspto-grants-2015_09
Patent number
US09120761B2

Reaction notes

Loading…